CLINICAL_TRIALS
trial_result
· 2019-10-22
Clinical Trial Update: Testosterone in Metastatic Renal Cell Carcinoma Patients [Phase 2]
Summary
A Phase 2 clinical trial investigating testosterone in patients with metastatic renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kidney Cancer Research Bureau | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED